Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
Medicus Pharma Ltd. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
- Exchange
- nasdaq
- Notice
- deficiency notice
- Deficiency
- minimum bid price
- Rules
- 5550(a)(2)
Exact text from the filing
April 21, 2026, the Company received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that the closing bid price for the Company's
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Medicus Pharma Ltd. amended Equity Distribution Agreement with Maxim Group LLC and Yorkville Securities, LLC valued at up to $50,000,000 (effective 2026-04-23).
- Action
- amendment
- Agreement
- atm program
- Counterparty
- Maxim Group LLC and Yorkville Securities, LLC
- Value
- up to $50,000,000
- Effective
- 2026-04-23
Exact text from the filing
the Company and the Agents entered into Amendment No. 1 to the Agreement (the "First Amendment", and together with the Agreement, the "Amended Agreement"), pursuant to which the Company increased the size of the aggregate offering amount from $15,349,674 to up to $50,000,000 (the "ATM Upsize")
View on SEC.gov